AU2001247334A1 - Novel peptides with anti-hypertensive activity - Google Patents
Novel peptides with anti-hypertensive activityInfo
- Publication number
- AU2001247334A1 AU2001247334A1 AU2001247334A AU4733401A AU2001247334A1 AU 2001247334 A1 AU2001247334 A1 AU 2001247334A1 AU 2001247334 A AU2001247334 A AU 2001247334A AU 4733401 A AU4733401 A AU 4733401A AU 2001247334 A1 AU2001247334 A1 AU 2001247334A1
- Authority
- AU
- Australia
- Prior art keywords
- novel peptides
- hypertensive activity
- hypertensive
- activity
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18849700P | 2000-03-10 | 2000-03-10 | |
| US60188497 | 2000-03-10 | ||
| PCT/US2001/007530 WO2001068114A1 (fr) | 2000-03-10 | 2001-03-09 | Nouveaux peptides a activite hypotensive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001247334A1 true AU2001247334A1 (en) | 2001-09-24 |
Family
ID=22693397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001247334A Abandoned AU2001247334A1 (en) | 2000-03-10 | 2001-03-09 | Novel peptides with anti-hypertensive activity |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001247334A1 (fr) |
| WO (1) | WO2001068114A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3028411B2 (ja) | 1997-09-26 | 2000-04-04 | カルピス株式会社 | トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌 |
| WO2000041572A1 (fr) | 1999-01-11 | 2000-07-20 | Calpis Co., Ltd. | Procede de production de lait fermente renfermant un peptide inhibiteur de l'enzyme de conversion de l'angiotensine et procede de production de lactoserum |
| JP4633876B2 (ja) | 1999-11-11 | 2011-02-16 | カルピス株式会社 | トリペプチドの製造方法 |
| JP2002193817A (ja) | 2000-12-28 | 2002-07-10 | Calpis Co Ltd | 整腸剤 |
| DE10105038B4 (de) | 2001-02-05 | 2005-07-07 | Neurotell Ag | Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems |
| DE10105041A1 (de) | 2001-02-05 | 2002-08-14 | Tell Pharm Ag Hergiswil | Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten |
| DE10105040A1 (de) | 2001-02-05 | 2002-08-14 | Tell Pharm Ag Hergiswil | Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems |
| WO2003102195A1 (fr) | 2002-06-04 | 2003-12-11 | Dsm Ip Assets B.V. | Hydrolysat de proteines riche en tripeptides |
| EP1534314B1 (fr) * | 2002-09-04 | 2014-10-22 | DSM IP Assets B.V. | Composition nutritionnelle et thérapeutique d'un agent sensibilisant à l'insuline et d'une fraction peptidique |
| ATE349804T1 (de) | 2002-09-06 | 2007-01-15 | Ericsson Telefon Ab L M | Zusammengesetzter leistungsverstärker |
| US7335644B2 (en) | 2003-03-31 | 2008-02-26 | Council Of Scientific And Industrial Research | Anti-hypertensive molecules and process for preparation thereof |
| BRPI0416712A (pt) * | 2003-12-15 | 2007-01-16 | Unilever Nv | uso de tripeptìdeo xpp, produto alimentìcio e processo para a preparação de um produto alimentìcio |
| WO2006114441A1 (fr) * | 2005-04-28 | 2006-11-02 | Dsm Ip Assets B.V. | Hydrolysats proteiques abaissant la pression arterielle |
| CN110734470B (zh) * | 2019-11-18 | 2021-04-16 | 浙江省农业科学院 | 一种降血脂的蚕蛹蛋白肽hpp及其应用 |
| CN117534727B (zh) * | 2023-12-21 | 2024-04-19 | 中国药科大学 | 一种食源性降压肽的制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691310A (en) * | 1987-09-29 | 1997-11-25 | Vesely; David L. | Methods of treatment using proANF peptides |
| US5854029A (en) * | 1996-08-02 | 1998-12-29 | Calpis Co., Ltd. | Method for preparing antihypertensive agent |
-
2001
- 2001-03-09 WO PCT/US2001/007530 patent/WO2001068114A1/fr not_active Ceased
- 2001-03-09 AU AU2001247334A patent/AU2001247334A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001068114A1 (fr) | 2001-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001291200A1 (en) | Micro-laser | |
| AU4943200A (en) | Modified cytokine | |
| AU7098000A (en) | Signed group criteria | |
| AU2001245537A1 (en) | Anti-hypertensive peptides | |
| AU6294199A (en) | Fastener | |
| AU2001278755A1 (en) | Injections | |
| AU3223100A (en) | Proteomic interaction arrays | |
| AU6045900A (en) | Interaction-activated proteins | |
| GB9912852D0 (en) | Peptides | |
| AU2001247334A1 (en) | Novel peptides with anti-hypertensive activity | |
| AU2001284418A1 (en) | Novel polypeptide | |
| AU6761600A (en) | Long duration infrared-emitting material | |
| AU4776800A (en) | Acetylcholinesterase-derived peptides and uses thereof | |
| AU2001263850A1 (en) | Pyrimidine-sulfonamides having endothelin-antagonist activity | |
| AU2001282880A1 (en) | Proteins with integrin-like activity | |
| GB9904695D0 (en) | Peptide | |
| EP1147130A4 (fr) | Peptides d'alpha-conotoxine | |
| AU2001244863A1 (en) | Apoptin-associating protein | |
| GB9908920D0 (en) | Peptide | |
| AU2001236101A1 (en) | Polypeptide having phosphodiesterase activity | |
| AU1540701A (en) | Novel protein | |
| GB0120713D0 (en) | Peptides | |
| AU2001278975A1 (en) | Alpha-conotoxin peptides | |
| AU2002500A (en) | Novel protein | |
| AU2109200A (en) | Polypeptide |